Post Categories
Research on Extending Lifespan with Cell Reprogramming Yields “Cautious Optimism”
February 13, 2023
Investors are pouring hundreds of millions of dollars into research designed to minimize the harms of aging through genetic engineering. The San Diego-based biotech,…
Experimental mRNA Vaccine Takes a Multivalent Approach to the Flu
February 6, 2023
The events of the COVID-19 pandemic have largely upended how we perceive and respond to global viral threats. One positive change is the technology…
Discovery: Pupal Ants Produce Milk for Their Colonies
February 1, 2023
Pupating ants produce milk — and scientists have only just noticed. Research published in Nature in November describes researchers observing for the first time…
The Resurgence of Strep A and the Effects of the COVID-19 Pandemic
January 30, 2023
An unexpected increase in cases of streptococcal A (strep A) infection in the United Kingdom is troubling for families, healthcare practitioners, and researchers. Although…
Pigs Could Solve the Organ Transplant Crisis
January 25, 2023
2022 held a number of significant breakthroughs in researchers’ ongoing efforts to solve the organ transplant crisis. Many of those breakthroughs were in xenotransplantation,…
The Unlikely Role of Hops in the Prevention of Alzheimer’s Disease
January 23, 2023
A team of Italian scientists from the University of Milan-Bicocca have recently discovered a possible use of hops, the flowers used to enhance both…
Costly, Life-Changing Type 1 Diabetes Drug Delays Disease, Receives FDA Approval
January 16, 2023
The U.S. Food and Drug Administration has approved teplizumab-mzw (TZIELD™), a drug developed by New Jersey-based Provention Bio to delay the onset of type…
A Breakthrough in Converting Brain Waves to Speech
January 11, 2023
A new pilot study conducted by Chang Lab at UC San Francisco has demonstrated the ability to use new neurotechnology to enable paralyzed individuals…
The Modern Quest for the Fountain of Youth
January 9, 2023
Quests for anti-aging solutions, usually the stuff of science fiction, have been revived with research into cellular reprogramming. More than 15 years ago, researchers…
Attacking KRAS Proteins to Kill Cancer
December 14, 2022
Recent advancements have led to the development of new cancer therapies that target mutations in KRAS proteins, which were once considered untreatable. In 2021,…
Offering Pain Relief Without Opioids, Vertex’s Sodium Channel Blocker Advances
December 12, 2022
Opioid pain relievers are highly addictive, contributing to high rates of opioid use disorder and overdose. According to the World Health Organization, opioid use…
Children with Retinitis Pigmentosa to See the World
December 7, 2022
Retinitis pigmentosa is a degenerative eye condition that slowly destroys the retina, the light-sensitive tissue at the back of the eye. For Canadian couple…
mRNA Cancer Vaccine Shows Promise Against Glioblastoma
July 8, 2024
In a pioneering first-in-human clinical trial, an mRNA cancer vaccine developed at the University of Florida (UF) has shown promise in treating patients with…
Cheating & Cooperating: How Viruses Communicate
June 19, 2024
Since their discovery in the late 1800s, viruses have been considered simple organisms largely incapable of communication. But today’s virologists have changed their tune;…
RNA Editing: A Safer Alternative in Genetic Medicine?
June 17, 2024
RNA editing is emerging as a promising and potentially safer alternative to therapies that modify an individual’s DNA. In December 2023, patients were treated…
CAR-T Cell Therapy Shows Promise in Treating Aggressive Brain Tumors
June 13, 2024
Around 200,000 people die from glioblastoma, the most common and most aggressive type of cancerous brain tumor, each year. With a five-year overall survival…
The CAR-T Conundrum: Are Cutting-Edge Therapies Causing Cancer?
June 10, 2024
In November 2023, the U.S. Food and Drug Administration (FDA) announced an investigation into chimeric antigen receptor (CAR) T-cell therapies, questioning if these promising…
Weight Loss Rebounding: The Challenges of Stopping Obesity Drugs
June 3, 2024
Semaglutide, under the brand names Wegovy® and Ozempic®, has surged in popularity for its ability to help people lose weight and reduce the risk…
Introduction Real-world evidence (RWE) is accelerating drug development by using routinely collected patient health data, known as real-world data (RWD), to deliver insights beyond…
Introduction Researchers are developing novel, safer treatments for cancer, but bringing new oncology therapies to market is challenging. This white paper will examine the…
Introduction As global obesity rates continue to rise, the search for effective treatments is more critical than ever. Obesity is associated with an increased…
NEWARK, Del.—(BUSINESS WIRE)—QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalytics and clinical trials, is celebrating its 30-year anniversary in…
NEWARK, Del.—(BUSINESS WIRE)—QPS India, a subsidiary of QPS Holdings, LLC (QPS), a GLP/GCP-compliant global full-service Contract Research Organization, has achieved another significant milestone by…
TAIPEI, Taiwan—(BUSINESS WIRE)—QPS, a leading global contract research organization (CRO) specializing in preclinical and clinical drug development services, is pleased to announce the expansion…
